Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.
Condition: Non-small Cell Lung Cancer Interventions: Drug: TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules; Drug: TQB2450 matching placebo, docetaxel injection, AL2846 matching placebo Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials
Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
Conditions: Breast Cancer; HER2-positive Breast Cancer Interventions: Drug: Albumin paclitaxel+trastuzumab+pyrrolitinib; Drug: Docetaxel+Carboplatin+trastuzumab+Parstuzumab Sponsor: Henan Cancer Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2023 Category: Research Source Type: clinical trials
